<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03646422</url>
  </required_header>
  <id_info>
    <org_study_id>FAE-LIN-2016-01</org_study_id>
    <nct_id>NCT03646422</nct_id>
  </id_info>
  <brief_title>AEDV Registry of Primary Cutaneous Lymphoma</brief_title>
  <official_title>Spanish Academy of Dermatology and Venereology (AEDV) Registry of Primary Cutaneous Lymphoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Academia Española de Dermatología</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Academia Española de Dermatología</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Registry of patients with Primary Cutaneous Lymphoma seen at participating centers in Spain.
      The registry will identify patients with this disease and includes information about stage,
      diagnostic and therapeutic interventions and willingness to participate in further studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Registry of patients with Primary Cutaneous Lymphoma seen at participating centers in Spain.
      The registry will identify patients with this disease and includes information about stage,
      diagnostic and therapeutic interventions and willingness to participate in further studies.

      Data is entered in the registry in each of the participating cutaneous lymphoma clinics.
      These data are updated at least yearly. Participants receive specific training before
      starting, and there is an online continuous monitoring system.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Maximum TNM stage</measure>
    <time_frame>Through study completion, an average every 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Therapeutic groups used</measure>
    <time_frame>Through study completion, an average every 1 year</time_frame>
    <description>Including drugs, phototherapy, radiotherapy and procedures (blood marrow transplant)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Through study completion, an average every 1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Lymphoma, T-Cell, Cutaneous</condition>
  <condition>Lymphoma, B-Cell, Marginal Zone</condition>
  <condition>Lymphoma, Large B-Cell, Diffuse</condition>
  <condition>Sezary Syndrome</condition>
  <condition>Lymphoma, Extranodal NK-T-Cell</condition>
  <condition>Lymphoma, B-Cell</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registry of patients (exposure is Cutaneous Lymphoma)</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population should be an accurate representation of patients with primary cutaneous
        lymphoma in Spain
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive patients with primary cutaneous lymphoma

        Exclusion Criteria:

          -  Not willing to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ignacio Garcia-Doval</last_name>
    <phone>+34 91 544 62 84</phone>
    <email>investigacion@AEDV.ES</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Estrach Panella</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Basurto</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa Izu Belloso</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prado Sanchez Caminero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>hospital Universitari de Bellvitge</name>
      <address>
        <city>L'Hospitalet De Llobregat</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Octavio Servitje Bedate</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>C.H.U. Insular-Materno Infantil</name>
      <address>
        <city>Las Palmas De Gran Canaria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeray Peñate Santana</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U. Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salma Machan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Ortiz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Príncipe de Asturias</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susana Medina Montalvo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Ignacio Yanguas Bayona</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHOP-Hospital de Montecelo</name>
      <address>
        <city>Pontevedra</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ángeles Flórez Menéndez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U. Nuestra Señora de la Candelaria</name>
      <address>
        <city>Santa Cruz De Tenerife</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Fernandez de Misa Cabrera</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U. Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Morillo Andújar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amparo Pérez Ferrer Ferriols</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Valencia-Clínico Malva-Rosa</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Dolores Ramón Quiles</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://aedv.es/investigacion/proyectos-de-investigacion/registro-de-linfomas/</url>
    <description>Updated description of the study (in Spanish)</description>
  </link>
  <reference>
    <citation>Peñate Y, Servitje O, Machan S, Fernández-de-Misa R, Estrach MT, Acebo E, Mitxelena J, Ramón MD, Flórez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Pérez A, Gónzalez-Romero N, Domínguez JD, Muniesa C, López Robles J, Combalia A, Yanguas I, Suh H, Polo-Rodríguez I, Bielsa I, Mateu A, Ferrer B, Descalzo MA, García-Doval I, Ortiz-Romero PL. The First Year of the AEVD Primary Cutaneous Lymphoma Registry. Actas Dermosifiliogr. 2018 Sep;109(7):610-616. doi: 10.1016/j.ad.2018.03.006. Epub 2018 Apr 19. English, Spanish.</citation>
    <PMID>29680323</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 18, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>November 21, 2018</last_update_submitted>
  <last_update_submitted_qc>November 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Sezary Syndrome</mesh_term>
    <mesh_term>Lymphoma, B-Cell</mesh_term>
    <mesh_term>Lymphoma, Large B-Cell, Diffuse</mesh_term>
    <mesh_term>Lymphoma, T-Cell</mesh_term>
    <mesh_term>Lymphoma, T-Cell, Cutaneous</mesh_term>
    <mesh_term>Lymphoma, Extranodal NK-T-Cell</mesh_term>
    <mesh_term>Lymphoma, B-Cell, Marginal Zone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

